Skip to main content
Equibles
CYRX logo

CYRX · Cryoport, Inc. · Webcasts, Transcripts & Audio

Track CYRX — free

Use CYRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CYRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.29 -0.35 (-1.88%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$944.10M
Shares
50.65M
Volume · Oct 29 1.85M Avg daily vol (3M) 651.39K

Cryoport, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Cryoport, Inc. (CYRX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-05
Cryoport, Inc. (CYRX) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-06
Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript
Confident tone Revenue growth and guidance Cell and gene therapy commercial and clinical growth IntegraCell cryopreservation services
Revenue
$48.97M
▲ 7.7% YoY
Diluted EPS
$-0.20
▼ 109.4% YoY
Gross margin
46.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-04
Cryoport, Inc. (CYRX) Q1 2026 Earnings Call Transcript
Confident tone Cell and gene therapy commercial pipeline Revenue growth and segment performance IntegraCell cell therapy manufacturing
Revenue
$47.80M
▲ 16.5% YoY
Diluted EPS
$-0.25
Gross margin
45.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-03
Cryoport, Inc. (CYRX) Q4 2025 Earnings Call Transcript
Positive tone MVE Biological Solutions and cryogenic products Commercial cell and gene therapy revenue growth Financial performance and guidance
Revenue
$45.45M*
▲ 9.6% YoY
Gross margin
47.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Cryoport, Inc. (CYRX) Q3 2025 Earnings Call Transcript
Confident tone Life Sciences Products / MVE cryogenic systems Cell and gene therapy commercial support growth Life Sciences Services segment performance
Revenue
$44.23M
▲ 15.4% YoY
Diluted EPS
$-0.18
Gross margin
48.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Cryoport, Inc. (CYRX) Q2 2025 Earnings Call Transcript
Confident tone MVE Products and Animal Health Demand Pathway to Profitability and Margin Expansion FDA/Regulatory Headwinds and Client Setbacks
Revenue
$45.45M
▲ 14.5% YoY
Diluted EPS
$2.13
Gross margin
47.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Cryoport, Inc. (CYRX) Q1 2025 Earnings Call Transcript
Confident tone DHL Strategic Partnership Tariffs and Supply Chain Cell and Gene Therapy Commercial Growth
Revenue
$41.04M
▲ 10.1% YoY
Diluted EPS
$-0.28
Gross margin
45.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-04
Cryoport, Inc. (CYRX) Q4 2024 Earnings Call Transcript
Positive tone Cost management and gross margin improvement MVE / Life Sciences Products stabilization IntegriCell cryopreservation launch
Revenue
$41.45M*
Gross margin
47.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Cryoport, Inc. (CYRX) Q3 2024 Earnings Call Transcript
Positive tone Life Sciences Services growth Cost reduction and profitability IntegriCell and CRYOGENE expansion
Revenue
$38.32M
▼ 31.8% YoY
Diluted EPS
$-0.02
Gross margin
45.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Cryoport, Inc. (CYRX) Q2 2024 Earnings Call Transcript
Positive tone Path to Profitability and Adjusted EBITDA China Market Challenges Cell and Gene Therapy Commercial Ramp
Revenue
$39.71M
▼ 30.4% YoY
Diluted EPS
$-1.62
Gross margin
44.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Cryoport, Inc. (CYRX) Q1 2024 Earnings Call Transcript
Cautious tone MVE Cryogenic Systems Weakness BioStorage/BioServices Growth Cell and Gene Therapy Momentum
Revenue
$37.29M
▼ 40.6% YoY
Diluted EPS
$-0.43
Gross margin
40.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-12
Cryoport, Inc. (CYRX) Q4 2023 Earnings Call Transcript
Positive tone MVE Biological Solutions 2024 Guidance and Conservative Outlook CRYOPDP U.S. Expansion
Revenue
−$7.33M*
▼ 112.1% YoY
Gross margin
10.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Cryoport, Inc. (CYRX) Q3 2023 Earnings Call Transcript
Revenue
$56.16M
▼ 7.1% YoY
Diluted EPS
$-0.31
Gross margin
43.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Cryoport, Inc. (CYRX) Q2 2023 Earnings Call Transcript
Revenue
$57.02M
▼ 11.1% YoY
Diluted EPS
$-0.42
Gross margin
43.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Cryoport, Inc. (CYRX) Q1 2023 Earnings Call Transcript
Revenue
$62.82M
▲ 20.1% YoY
Diluted EPS
$-0.16
Gross margin
43.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Cryoport, Inc. (CYRX) Q4 2022 Earnings Call Transcript
Revenue
$60.36M
▲ 6.9% YoY
Diluted EPS
$-0.24
Gross margin
43.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Cryoport, Inc. (CYRX) Q3 2022 Earnings Call Transcript
Revenue
$60.46M
▲ 6.7% YoY
Diluted EPS
$-0.15
Gross margin
43.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Cryoport, Inc. (CYRX) Q2 2022 Earnings Call Transcript
Revenue
$64.15M
▲ 14.2% YoY
Diluted EPS
$-0.23
Gross margin
45.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Cryoport, Inc. (CYRX) Q1 2022 Earnings Call Transcript
Revenue
$52.30M
▼ 1.8% YoY
Diluted EPS
$-0.31
Gross margin
42.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Cryoport, Inc. (CYRX) Q4 2021 Earnings Call Transcript
Revenue
$56.44M
▲ 16.7% YoY
Diluted EPS
$-5.46
Gross margin
41.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Cryoport, Inc. (CYRX) Q3 2021 Earnings Call Transcript
Revenue
$56.69M
▲ 407.5% YoY
Diluted EPS
$-0.18
Gross margin
41.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Cryoport, Inc. (CYRX) Q2 2021 Earnings Call Transcript
Revenue
$56.19M
▲ 498.5% YoY
Diluted EPS
$-0.16
Gross margin
45.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Cryoport, Inc. (CYRX) Q1 2021 Earnings Call Transcript
Revenue
$53.28M
▲ 445.2% YoY
Diluted EPS
$-0.13
Gross margin
46.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-01-20
Cryoport, Inc. (CYRX) Q4 2020 Earnings Call Transcript
Revenue
$48.36M
▲ 423.3% YoY
Diluted EPS
$-1.32
Gross margin
41.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Cryoport, Inc. (CYRX) Q3 2020 Earnings Call Transcript
Revenue
$11.17M
▲ 16.6% YoY
Diluted EPS
$-0.29
Gross margin
54.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-07
Cryoport, Inc. (CYRX) Q2 2020 Earnings Call Transcript
Revenue
$9.39M
▲ 10.9% YoY
Diluted EPS
$-0.15
Gross margin
54.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Cryoport, Inc. (CYRX) Q1 2020 Earnings Call Transcript
Revenue
$9.77M
▲ 46.9% YoY
Diluted EPS
$-0.11
Gross margin
53.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-05
Cryoport, Inc. (CYRX) Q4 2019 Earnings Call
Revenue
$9.24M
▲ 62.4% YoY
Gross margin
53.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 webcasts
Key facts CIK 1124524 CUSIP 229050307 13F (30d) 29 filings 29 filers Visit website Investor relations